论文部分内容阅读
目的:分析研讨小剂量肾上腺素在重症支气管哮喘急救中的应用价值。方法:本次讨论中所研讨的66例患者均随机从我院2015年8月至2016年7月期间收治的重症支气管哮喘患者中筛选而出,将其随机分两组,33例对照组(常规方式)和33例研究组(小剂量肾上腺素),将两组治疗效果、各项临床指标进行对比研讨。结果:两组患者治疗前呼吸频率、心率、血氧饱和度均无明显差异(P>0.05);经治疗后,两组患者各项指标均明显改善,但研究组比对照组改善更显著,组间数据有统计学意义(P<0.05);研究组患者的治疗总有效率100%比对照组81.82%高,组间数据有统计学意义(P<0.05)。结论:将小剂量肾上腺素应用于重症支气管哮喘急救中,可快速、有效地缓解病人的临床症状,提高病人的生存率,值得推广。
Objective: To analyze the value of low-dose epinephrine in the emergency treatment of severe bronchial asthma. Methods: All the 66 patients studied in this study were randomly selected from patients with severe bronchial asthma admitted from August 2015 to July 2016 in our hospital. They were randomly divided into two groups and 33 control group Conventional way) and 33 cases of study group (small dose of epinephrine), the two groups of treatment, clinical indicators for comparative study. Results: There were no significant differences in respiratory rate, heart rate and oxygen saturation before treatment in both groups (P> 0.05). After treatment, the indexes in both groups were significantly improved, but the study group improved more significantly than the control group, The data of the two groups were statistically significant (P <0.05). The total effective rate of the study group was 100% higher than that of the control group (81.82%). There was significant difference between the two groups (P <0.05). Conclusion: The low dose of epinephrine used in emergency treatment of severe bronchial asthma can quickly and effectively alleviate the clinical symptoms of patients and improve the survival rate of patients, it is worth promoting.